5-HT |
serotonin (5-hydroxytryptamine) |
ALS |
amyotrophic lateral sclerosis |
ASM |
antiseizure medication |
BDNF |
brain-derived neurotrophic factor |
BIC |
bicuculline |
BiP |
immunoglobulin-binding protein |
BRIEF |
Behavior Rating Index of Executive Function |
CA3 |
cornu ammonis subfield 3 |
CaM |
calmodulin |
CDD |
CDKL5-associated disorder |
CNS |
central nervous system |
DEE |
developmental and epileptic encephalopathy |
DHEA |
dehydroepiandrosterone |
DHEAS |
dehydroepiandrosterone sulfate |
EEG |
electroencephalogram/electroencephalographic |
ER |
endoplasmic reticulum |
FTLD |
frontotemporal lobar dementia |
GABA |
γ-aminobutyric acid |
GTC |
generalized tonic-clonic |
GTPase |
hydrolase enzyme of guanosine triphosphate |
HINT1 |
histidine triad nucleotide binding protein 1 (HINT1) |
i.c.v. |
intracerebroventricular |
iNOS |
inducible nitric oxide synthase |
IP3R |
inositol triphosphate receptor |
LFP |
local field potential |
MAM |
mitochondria-associated membrane |
mTOR |
mechanistic target of rapamycin |
NFκB |
nuclear factor κB |
NMDA |
N-methyl-d-aspartate |
NMDAR |
N-methyl-d-aspartate receptor |
OCD |
obsessive-compulsive disorder |
PNS |
peripheral nervous system |
PREGS |
pregnenolone sulfate |
PTZ |
pentylenetetrazol |
ROS |
reactive oxygen species |
Sigma1R |
sigma-1 receptor |
SNRI |
serotonin-norepinephrine reuptake inhibitor |
SSRI |
selective serotonin reuptake inhibitor |
SUDEP |
sudden unexpected death in epilepsy |
TRP |
transient receptor potential |
UTR |
untranslated region |